ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
批准号:
2703206
负责人:
Stanley H. Appel
金额:
$2.58万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-01 至 1999-04-30
关键词:
amyotrophic lateral sclerosis apoptosis calbindin calcium binding protein calcium channel calcium channel blockers calcium flux calcium metabolism cellular pathology confocal scanning microscopy cytotoxicity dosage electron microscopy electrophysiology homeostasis immunocytochemistry immunoglobulin G laboratory mouse motor neurons neuromuscular transmission neurotransmitter transport pharmacokinetics protein structure synaptic vesicles tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Amyotrophic lateral sclerosis is a devastating neuromuscular disease which
produces progressive weakness leading eventually to respiratory failure and
death. Our long term objective is to define the role of immunological
factors in the etiology and pathogenesis of ALS. Although the etiology is
still unknown, recent evidence suggests that immune mechanisms may play a
role in triggering motoneuron injury and cell death. Results of in vitro
experiments suggest that ALS IgG interact with neuronal voltage gated
calcium channels resulting in excess calcium influx and calcium mediated
neuronal injury. However, ALS in man is a slowly progressive pathologic
condition whereas ALS IgG in vitro has a fast killing potency. Our present
investigations are aimed at characterizing the evolution of ultrastructural
changes and alterations of calcium levels of motoneurons exposed to ALS IgG
in vivo by passive transfer to mice. Such investigations should help to
define neuronal injury at its earliest stage, and may fill the gap; between
the slowly evolving changes in ALS and the result of model experiments.
Accordingly, the specific aims are:
(1) To determine the time/dose dependence of effects of ALS IgG on
ultrastructure and intracellular calcium level of motoneurons of mice
injected with ALS IgG
(2) To determine the specificity of ALS IgG by substituting ALS IgG with
disease control IgG, by preadsorption of ALS IgG with potential membrane
targets (purified calcium channels) and by antagonizing their effect with
Ca-channel blockers.
(3) To provide a detailed electrophysiological and ultrastructural study
of transmitter release and vesicle recycling after in vivo IgG injection
into mice.
For these studies, mice will be injected intraperitoneally with different
dosages of ALS IgG followed by perfusion fixation for ultrastructural
analysis at different time points. An oxalate-ion containing
glutaraldehyde fixative will be applied to provide good ultrastructural
preservation and simultaneous conservation of in situ calcium distribution.
Morphological and intracellular calcium distributional changes will be
assayed by quantitative electron microscopy at motor nerve terminals,
intramuscular axons and cell bodies of motoneurons with different
susceptibility to ALS and the changes will be related to appropriate
controls. In parallel experiments ALS IgG induced changes in neuromuscular
transmission will be characterized by measuring changes in miniature end-
plate potential frequency and by tracking synaptic vesicle recycling with
immunohistochemical methods utilizing antibodies against vesicle proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Blocking TLR-Activation of Regulatory T cells Slows Disease in ALS
-
批准号:8491387
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2013
-
负责人:Stanley H. Appel
-
依托单位:
Blocking TLR-Activation of Regulatory T cells Slows Disease in ALS
-
批准号:8635400
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2013
-
负责人:Stanley H. Appel
-
依托单位:
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IN
-
批准号:8356778
-
项目类别:
-
资助金额:$3.13万
-
财政年份:2010
-
负责人:Stanley H. Appel
-
依托单位:
Using CD4+ T cells as a candidate therapy to slow disease progression in ALS
-
批准号:7774428
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2010
-
负责人:Stanley H. Appel
-
依托单位:
Using CD4+ T cells as a candidate therapy to slow disease progression in ALS
-
批准号:8022831
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2010
-
负责人:Stanley H. Appel
-
依托单位:
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IND
-
批准号:8166775
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:7117593
-
项目类别:
-
资助金额:$29.27万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:7247115
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:6808484
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:6898178
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6318257
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2000
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6218712
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1999
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6098188
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1999
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6295500
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1999
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6295508
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1998
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6267426
-
项目类别:
-
资助金额:$12.66万
-
财政年份:1998
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6234197
-
项目类别:
-
资助金额:$11.97万
-
财政年份:1997
-
负责人:Stanley H. Appel
-
依托单位:
ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
-
批准号:2416484
-
项目类别:
-
资助金额:$2.59万
-
财政年份:1996
-
负责人:Stanley H. Appel
-
依托单位:
ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
-
批准号:2292257
-
项目类别:
-
资助金额:$2.58万
-
财政年份:1996
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE NEURONAL VULNERABILITY IN SPORADIC ALS
-
批准号:2271818
-
项目类别:
-
资助金额:$24.51万
-
财政年份:1994
-
负责人:Stanley H. Appel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: